Tower Research Capital LLC (Trc) Tyra Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 874 shares of TYRA stock, worth $13,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
874
Previous 2,840
69.23%
Holding current value
$13,581
Previous $27,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TYRA
# of Institutions
114Shares Held
58.1MCall Options Held
23.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$190 Million2.93% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$63 Million8.64% of portfolio
-
Nextech Invest Ag4.06MShares$63 Million10.51% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY3.82MShares$59.4 Million97.03% of portfolio
-
Bvf Inc San Francisco, CA3.65MShares$56.7 Million2.76% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $652M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...